Journal Article Summary

The article investigates the pharmacokinetics of levocetirizine in young children who are receiving cetirizine, a common antihistamine, as part of a long-term treatment plan. Understanding how medications behave in the body, especially in children at risk for asthma, is crucial for ensuring effective and safe treatment. This study is important because it helps clarify how dosing might need to be adjusted for young patients compared to adults, which can lead to better management of allergic conditions.

The researchers analyzed data from a study involving 343 children aged 12 to 24 months who were at high risk for asthma but had not yet developed the condition. The children received cetirizine for 18 months, and blood samples were taken at various points to measure levels of levocetirizine. The findings indicated that the clearance and volume of distribution of levocetirizine increased with the child's weight, suggesting that younger children metabolize the drug differently than adults. The study concluded that a dose of 0.125 mg/kg twice daily for children aged 12 to 48 months would provide similar drug exposure as the standard adult dose of 5 mg once daily.

However, the study has limitations, including potential issues with compliance among participants and inconclusive results regarding the impact of other medications or health conditions. Patients and caregivers should be aware that while the findings provide useful insights, individual responses to medication can vary. It is important for readers to discuss any concerns or questions about levocetirizine or cetirizine treatment with a healthcare professional to ensure safe and effective use tailored to their child's specific needs.

Medical Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Hussein Ziad, Pitsiu Maria, Majid Oneeb, Aarons Leon, de Longueville Marc, Stockis Armel. Retrospective population pharmacokinetics of levocetirizine in atopic children receiving cetirizine: the ETAC® study. British Journal of Clinical Pharmacology 2005. DOI: 10.1111/j.1365-2125.2005.02242.x. PMID: 15606437. PMCID: PMC1884967.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]